DD216017A5 - Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a - Google Patents
Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a Download PDFInfo
- Publication number
- DD216017A5 DD216017A5 DD83256672A DD25667283A DD216017A5 DD 216017 A5 DD216017 A5 DD 216017A5 DD 83256672 A DD83256672 A DD 83256672A DD 25667283 A DD25667283 A DD 25667283A DD 216017 A5 DD216017 A5 DD 216017A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- aza
- epi
- deoxo
- desoxo
- homoerythromycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
- Developing Agents For Electrophotography (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44197982A | 1982-11-15 | 1982-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD216017A5 true DD216017A5 (de) | 1984-11-28 |
Family
ID=23755068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD83256672A DD216017A5 (de) | 1982-11-15 | 1983-11-14 | Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0109253B1 (el) |
JP (1) | JPS59104398A (el) |
KR (1) | KR850000968B1 (el) |
AT (1) | ATE30237T1 (el) |
AU (1) | AU544790B2 (el) |
CA (1) | CA1239639A (el) |
CS (1) | CS241069B2 (el) |
DD (1) | DD216017A5 (el) |
DE (1) | DE3374065D1 (el) |
DK (1) | DK159322C (el) |
EG (1) | EG16641A (el) |
ES (2) | ES527249A0 (el) |
FI (1) | FI72980C (el) |
GR (1) | GR79425B (el) |
GT (1) | GT198304062A (el) |
HU (1) | HU193886B (el) |
IE (1) | IE56234B1 (el) |
IL (1) | IL70228A (el) |
NO (1) | NO160262C (el) |
NZ (1) | NZ206259A (el) |
PH (2) | PH19293A (el) |
PL (2) | PL142601B1 (el) |
PT (1) | PT77645B (el) |
SU (1) | SU1272996A3 (el) |
YU (2) | YU43198B (el) |
ZA (1) | ZA838460B (el) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4465674A (en) * | 1983-09-06 | 1984-08-14 | Pfizer Inc. | Azahomoerythromycin D derivative and intermediates therefor |
GR80277B (en) * | 1983-09-06 | 1985-01-04 | Pfizer | Azahomoerythromycin b derivatives and intermediates therefor |
RU2066324C1 (ru) * | 1987-07-09 | 1996-09-10 | Пфайзер Инк. | Кристаллический дигидрат азитромицина и способ его получения |
WO1989002271A1 (en) * | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycin and derivatives as antiprotozoal agents |
JP2751385B2 (ja) * | 1988-05-19 | 1998-05-18 | 大正製薬株式会社 | エリスロマイシンaオキシム及びその塩の製造方法 |
US5075289A (en) * | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
YU149889A (en) * | 1989-07-26 | 1991-02-28 | Pliva Zagreb | Process for preparing biologically active derivatives of tylozine |
US5912331A (en) * | 1991-03-15 | 1999-06-15 | Merck & Co., Inc. | Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A |
US5985844A (en) * | 1992-03-26 | 1999-11-16 | Merck & Co., Inc. | Homoerythromycin A derivatives modified at the 4"-and 8A-positions |
CA2064634C (en) * | 1991-04-04 | 1998-08-04 | James V. Heck | 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions |
CA2064985A1 (en) * | 1991-04-05 | 1992-10-06 | Robert R. Wilkening | 8a-aza-8a-homoertyhromycin cyclic lactams |
CA2065222A1 (en) * | 1991-04-09 | 1992-10-10 | Robert R. Wilkening | Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers |
EP0508795A1 (en) * | 1991-04-10 | 1992-10-14 | Merck & Co. Inc. | 8a-aza-8a-homoerythromycin cyclic iminoethers |
US5189159A (en) * | 1992-04-02 | 1993-02-23 | Merck & Co., Inc. | 8a-AZA-8a-homoerythromycin cyclic iminoethers |
CA2065218A1 (en) * | 1991-04-11 | 1992-10-12 | Robert R. Wilkening | Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives |
EP0515141A1 (en) * | 1991-05-20 | 1992-11-25 | Merck & Co. Inc. | Novel process for the preparation of 8A-aza-8A-homoerythromycin cyclic lactams |
EP0549040A1 (en) * | 1991-12-20 | 1993-06-30 | Merck & Co. Inc. | Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A |
US5215980A (en) * | 1992-01-17 | 1993-06-01 | Merck & Co., Inc. | 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof |
US5210235A (en) * | 1992-08-26 | 1993-05-11 | Merck & Co., Inc. | Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics |
HRP930014A2 (en) * | 1993-01-08 | 1994-08-31 | Pliva Pharm & Chem Works | 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates |
US5332807A (en) * | 1993-04-14 | 1994-07-26 | Merck & Co., Inc. | Process of producing 8A- and 9A-azalide antibiotics |
ES2163504T5 (es) * | 1994-05-06 | 2008-05-16 | Pfizer Inc. | Formas de dosificacion de liberacion controlada de azitromicina. |
PT102006B (pt) * | 1997-05-19 | 2000-06-30 | Hovione Sociedade Quimica S A | Novo processo de preparacao de azitromicina |
TW546302B (en) * | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
EP1437360A3 (en) * | 1998-08-19 | 2005-04-06 | Pfizer Products Inc. | C11 Carbamates of macrolide antibacterials |
US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
EP1206476B1 (en) * | 1999-08-24 | 2006-01-04 | Abbott Laboratories | 9a-azalides with antibacterial activity |
US6764996B1 (en) | 1999-08-24 | 2004-07-20 | Abbott Laboratories | 9a-azalides with antibacterial activity |
CA2396426A1 (en) * | 2000-01-04 | 2001-07-12 | Teva Pharmaceutical Industries Ltd. | Preparation method of azithromycin dihydrate |
WO2002015842A2 (en) | 2000-08-23 | 2002-02-28 | Wockhardt Limited | Process for preparation of anhydrous azithromycin |
US6852262B2 (en) | 2002-05-09 | 2005-02-08 | The Gillette Company | Insert molding razor cartridges |
BRPI0416534A (pt) | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | composições multiparticuladas com estabilidade melhorada |
DE602004014805D1 (de) | 2003-12-04 | 2008-08-14 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU43116B (en) * | 1979-04-02 | 1989-04-30 | Pliva Pharm & Chem Works | Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox |
JPS5788193A (en) * | 1980-11-21 | 1982-06-01 | Pliva Pharm & Chem Works | 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture |
YU43006B (en) * | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
US4382085A (en) * | 1982-03-01 | 1983-05-03 | Pfizer Inc. | 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents |
-
1983
- 1983-10-21 PH PH29751A patent/PH19293A/en unknown
- 1983-11-09 DE DE8383306815T patent/DE3374065D1/de not_active Expired
- 1983-11-09 EP EP83306815A patent/EP0109253B1/en not_active Expired
- 1983-11-09 AT AT83306815T patent/ATE30237T1/de not_active IP Right Cessation
- 1983-11-10 CA CA000440924A patent/CA1239639A/en not_active Expired
- 1983-11-11 PT PT77645A patent/PT77645B/pt unknown
- 1983-11-11 GT GT198304062A patent/GT198304062A/es unknown
- 1983-11-11 GR GR72951A patent/GR79425B/el unknown
- 1983-11-14 NO NO834146A patent/NO160262C/no not_active IP Right Cessation
- 1983-11-14 PL PL1983250350A patent/PL142601B1/pl unknown
- 1983-11-14 IL IL70228A patent/IL70228A/xx not_active IP Right Cessation
- 1983-11-14 DK DK518683A patent/DK159322C/da not_active IP Right Cessation
- 1983-11-14 SU SU833661803A patent/SU1272996A3/ru active
- 1983-11-14 IE IE2652/83A patent/IE56234B1/en not_active IP Right Cessation
- 1983-11-14 ES ES527249A patent/ES527249A0/es active Granted
- 1983-11-14 KR KR1019830005387A patent/KR850000968B1/ko not_active IP Right Cessation
- 1983-11-14 HU HU833902A patent/HU193886B/hu unknown
- 1983-11-14 NZ NZ206259A patent/NZ206259A/en unknown
- 1983-11-14 ZA ZA838460A patent/ZA838460B/xx unknown
- 1983-11-14 AU AU21309/83A patent/AU544790B2/en not_active Expired
- 1983-11-14 PL PL1983244557A patent/PL143281B1/pl unknown
- 1983-11-14 DD DD83256672A patent/DD216017A5/de not_active IP Right Cessation
- 1983-11-14 FI FI834163A patent/FI72980C/fi not_active IP Right Cessation
- 1983-11-15 CS CS838455A patent/CS241069B2/cs unknown
- 1983-11-15 JP JP58214928A patent/JPS59104398A/ja active Granted
- 1983-11-15 YU YU2243/83A patent/YU43198B/xx unknown
- 1983-11-15 EG EG717/83A patent/EG16641A/xx active
-
1985
- 1985-02-28 PH PH31922A patent/PH21560A/en unknown
- 1985-05-29 ES ES543638A patent/ES8604257A1/es not_active Expired
- 1985-12-17 YU YU1972/85A patent/YU43425B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD216017A5 (de) | Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a | |
DE2618822C3 (de) | Anthracyclin-Glycoside und Verfahren zu deren Herstellung | |
US4526889A (en) | Epimeric azahomoerythromycin A derivative, intermediates and method of use | |
JPH01193292A (ja) | N−メチル11−アザ−10−デオキソ−10−ジヒドロエリスロマイシンa製造用中間体 | |
DE2346535B2 (de) | Verfahren zur Herstellung von 7-Dimethylamino-e-desmethyl-e-desoxytetracyclin über 9-tert.Butyl-6-desmethyl-6-desoxytetracyclin | |
DE2411504C3 (de) | 6'-Substituierte 6'-Desoxylividomycine B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DD211565A5 (de) | Verfahren zur herstellung von 4"-epi-erythromycin a und derivaten hiervon als brauchbare antibakterielle mittel | |
US5023240A (en) | Derivatives of tylosin and 10,11,12,13-tetrahydro tylosin and their use in pharmaceuticals | |
DE2831579C3 (de) | Tetrahydropyranylether von Daunomycin und Adriamycin, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
CH636869A5 (en) | Process for the preparation of flavones | |
EP0136831A2 (en) | Azahomoerythromycin B derivatives and intermediates thereof | |
DE2366288C3 (de) | Verfahren zur Herstellung von 3' -Desoxykanamycin B und 3' -Desoxyneamin | |
DE2804507C2 (de) | 4"-Desoxy-4"-amino-erythromycin-A und dessen Derivate sowie diese Verbindungen enthaltende antibakterielle Mittel | |
DE2731306C3 (de) | 9-Desacetyl- und 9-Desacetyl-9-epi-daunorubicin, Verfahren zu deren Herstellung und deren Verwendung | |
DE3227178C2 (de) | 2'-Modifizierte Kanamycine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel | |
CH642973A5 (de) | Antitumoranthracycline mit verzweigtkettigen aminodeoxyzuckerresten. | |
DE69418715T2 (de) | Erythromycinderivate | |
DE3641835A1 (de) | Zytostatisch wirksame anthracyclinderivate | |
DE2756057A1 (de) | Verfahren zur herstellung von 3',4'-dideoxykanamycin b | |
DE3009910C2 (de) | 3',4'-Diepi-4'-O-methyl-daunorubicin und -doxorubicin, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
CH642975A5 (de) | 4''-deoxy-4''-glyoxamido- und -carbonylthioformamidoderivate von oleandomycin und dessen estern, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
CA1250284A (en) | Antibacterial epimeric azahomoerythromycin a derivative and production thereof | |
DE69200900T2 (de) | 1,5-Diyn-3-cycloalkenderivate, ihr Herstellungsverfahren und diese enthaltende pharmazeutische Compositionen. | |
AT360159B (de) | Verfahren zur herstellung von neuen 4''-amino- -oleandomycinen | |
DE2633913A1 (de) | 6'-hydroxyderivate von antitumoranthracyclinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NPV | Change in the person, the name or the address of the representative (addendum to changes before extension act) | ||
ENJ | Ceased due to non-payment of renewal fee |